Reinhard Kandera - Net Worth and Insider Trading

Reinhard Kandera Net Worth

The estimated net worth of Reinhard Kandera is at least $39,373 dollars as of 2024-05-02. Reinhard Kandera is the CFO of HOOKIPA Pharma Inc and owns about 43,092 shares of HOOKIPA Pharma Inc (HOOK) stock worth over $39,373. Details can be seen in Reinhard Kandera's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Reinhard Kandera has not made any transactions after 2023-08-21 and currently still holds the listed stock(s).

Transaction Summary of Reinhard Kandera

To

Reinhard Kandera Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Reinhard Kandera owns 1 companies in total, including HOOKIPA Pharma Inc (HOOK) .

Click here to see the complete history of Reinhard Kandera’s form 4 insider trades.

Insider Ownership Summary of Reinhard Kandera

Ticker Comapny Transaction Date Type of Owner
HOOK HOOKIPA Pharma Inc 2023-08-21 director & Chief Financial Officer

Reinhard Kandera Latest Holdings Summary

Reinhard Kandera currently owns a total of 1 stock. Reinhard Kandera owns 43,092 shares of HOOKIPA Pharma Inc (HOOK) as of August 21, 2023, with a value of $39,373.

Latest Holdings of Reinhard Kandera

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOOK HOOKIPA Pharma Inc 2023-08-21 43,092 0.91 39,373

Holding Weightings of Reinhard Kandera


Reinhard Kandera Form 4 Trading Tracker

According to the SEC Form 4 filings, Reinhard Kandera has made a total of 3 transactions in HOOKIPA Pharma Inc (HOOK) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in HOOKIPA Pharma Inc is the acquisition of 7,000 shares on August 21, 2023, which cost Reinhard Kandera around $5,110.

Insider Trading History of Reinhard Kandera

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Reinhard Kandera Trading Performance

GuruFocus tracks the stock performance after each of Reinhard Kandera's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Reinhard Kandera is -33.54%. GuruFocus also compares Reinhard Kandera's trading performance to market benchmark return within the same time period. The performance of stocks bought by Reinhard Kandera within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Reinhard Kandera's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Reinhard Kandera

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.24
Relative Return to S&P 500(%) -11.05

Reinhard Kandera Ownership Network

Ownership Network List of Reinhard Kandera

No Data

Ownership Network Relation of Reinhard Kandera


Reinhard Kandera Owned Company Details

What does HOOKIPA Pharma Inc do?

Who are the key executives at HOOKIPA Pharma Inc?

Reinhard Kandera is the director & Chief Financial Officer of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Executive Officer Jorn Aldag , Chief Medical Officer Katia Schlienger , and 10 percent owner Gilead Sciences Inc .

HOOKIPA Pharma Inc (HOOK) Insider Trades Summary

Over the past 18 months, Reinhard Kandera made 3 insider transaction in HOOKIPA Pharma Inc (HOOK) with a net purchase of 27,000. Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 20,000 shares made by Jorn Aldag ,

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 47,000 shares were bought by its insiders, resulting in a net purchase of 47,000 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

HOOKIPA Pharma Inc Insider Transactions

No Available Data

Reinhard Kandera Mailing Address

Above is the net worth, insider trading, and ownership report for Reinhard Kandera. You might contact Reinhard Kandera via mailing address: C/o Hookipa Pharma Inc., 430 East 29th St., 14th Floor, New York Ny 10016.

Discussions on Reinhard Kandera

No discussions yet.